Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,239
Out of 4,944 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $12.95 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $68.98 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $308.68 | +3.67% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $92.91 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $36.70 | +30.79% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $155.97 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $6.04 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $166.86 | -52.06% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $6.24 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $44.91 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $129.40 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $102.50 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $79.96 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $77.68 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $12.95
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $68.98
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $308.68
Upside: +3.67%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $92.91
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $36.70
Upside: +30.79%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $155.97
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $6.04
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $166.86
Upside: -52.06%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $6.24
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $44.91
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $129.40
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $102.50
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $79.96
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $77.68
Upside: -